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Despite funding concerns and varying political policies, it
is tempting to think that within health care in the UK,
the core professions remain enduring pillars of stability,
and perhaps never more so than in the recent COVID-19
pandemic. However, the community pharmacy and com-
munity pharmacist professional role may be under signifi-
cant threat. Enduring sociological criticism, failure to act
on policy recommendations, remuneration issues, dis-
pensing automation and ambiguous public health roles all
conspire to threaten their existence.
It is now more than half a century since sociological
scrutiny was directed critically on the community phar-
macy setting. It was damningly considered an ‘incomplete
profession’[1] struggling to reconcile commercial and
altruistic professional demands, and without sufficient
control of the social object of the ‘drug’.[2] Further analy-
sis has variously qualified or perpetuated this and even if
the social object of the ‘medicine’ did have important
social value (evidenced most obviously in rising prescrib-
ing trends), a decision was needed as to whether phar-
macy should focus on the medicine or the patient.[3] The
rise of GP practice-based pharmacists, non-medical pre-
scribing and recent advanced clinical practitioner roles
has exacerbated this divide, with community pharmacists
having little opportunity to take on such roles and
remaining associated with, and hampered by, the con-
tested medicine.
The plight of community pharmacy is all the more
frustrating as there have been decades of policy recom-
mendations, dating as far back as the Nuffield report of
the 1980s,[4] through Pharmacy in a New Age[5] to the
prescient Now or Never: Shaping the Future of Commu-
nity Pharmacy.[5] All recognised the need for pharmacy
to change and embrace new roles as traditional dispens-
ing practices changed. In part, this has occurred in the
UK, with considerably less emphasis (and remuneration)
for dispensing the social object of the medicine, and
more on advanced services. However, the decommission-
ing of high profile services such as the medicine use
review (MUR) and the faltering pilot of NUMSAS sent
warnings of an occupation struggling still to find viable
new roles.
At the heart of the policy agenda was recognition that
technological advances would render traditional pharmacy
roles obsolete. Original pack dispensing and the greater
use of information technology were traditional drivers for
change but arguably more recent threats have emerged in
relation to online pharmacies, and proposed ‘hub and
spoke’ models.[6] Both of these make much more likely
the possibility that medicines can be sent directly to
patients without the traditional pharmacist involvement.
A resulting ‘technology shock’ looms in which radical
changes to community pharmacy may occur, and how
the quality use of medicines can be protected, and even if
community pharmacies could continue to provide this.
Technology has been argued to change for the better and
pharmacy access to the summary care record, for exam-
ple, is a tangible attempt to connect community phar-
macy to other healthcare services. However, with 39% of
pharmacies in England reporting the equivalent of access
to only one patient record per month, it is debatable
again how much this has been a positive change.[7] What
emerges is a profession distanced from more explicit clin-
ical roles that follow a patient focus, and a continued reli-
ance on a medicines focus but with significant
technological threats to this relationship and potential
distancing of community pharmacy from those very
medicines potentially.
Are public health roles for community pharmacy the
solution? There is some evidence of the effectiveness of
smoking cessation and weight loss intervention in phar-
macies,[7] and flu vaccinations represent an important
additional public health role and advanced service. Addi-
tionally, one of the most recent policy documents about
the future role of community pharmacy has advocated
greater public health involvement.[8] However, such roles
raise two key issues: one is to what extent such roles suffi-
ciently protect the status of community pharmacy profes-
sionally, and secondly, based on the aforementioned
technological changes and potential separation of
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community pharmacy from medicines, will the public still
use the physical pharmacy? The first concern originates in
further analysis from the sociology of the professions and
claims relating to professional authority and indeed secu-
rity. These suggest that professional status requires protec-
tion and control of certain – often highly skilled – tasks,
as well as regulatory legitimacy and the maintenance of
professional boundaries and jurisdiction.[9] The process of
diversification and the adoption of new, or existing roles
in new settings, is a recognised activity which can allow a
profession to adapt. However, the public health related
services which community pharmacy are being recom-
mended to take on are not unique and are delivered in
other healthcare settings by occupational groups such as
nurses. As such, they represent a form of substitution and
not diversification.[9] The second concern relates to the
increasing use of hub and spoke approaches and associ-
ated cost saving, and why would the public be inclined to
visit a community pharmacy if their medicines are no
longer supplied there?[6] This undermines the argument
that the community pharmacy is a key setting in which to
extend public health activities. In addition, important
‘frames’ of reference for the public to understand com-
munity pharmacy roles might be even further ‘misaligned’
due to these changes, as seen potentially in other activities
such as the New Medicines Service.[10]
In summary, the community pharmacy and associated
role of the community pharmacist are significantly threat-
ened by a range of factors. However, are there any ways of
avoiding this demise? One key opportunity relates to the
lack of research and evidence relating to community phar-
macy, in terms of what patients and consumers want, and
of what pharmacy activities and interventions are effective
and cost effective. Without robust evidence, policy and
strategies relating to community pharmacy are weakened
and lack sufficient credibility. Providing opportunities for
the public to self-manage conditions and receive advice –
though minor ailments schemes for example – also remain
important activities which community pharmacies can pro-
vide. However, these still require adequate independent
remuneration if they are to avoid issues of commercial and
professional conflict.[1] Care is also needed to avoid claims
of pharmaceuticalisation and in an age of greater social
prescribing, an over-reliance on medicines as the perceived
default treatment. Despite the commendable current efforts
of community pharmacy in the current COVID-19 pan-
demic to ensure medicines are supplied and the public kept
safe, the future is less optimistic. The roles and opportuni-
ties for pharmacists in hospitals and locations such as GP
practices and primary care are more obvious and defensible
but for the community pharmacist, they appear all too
mortal.
References
1. Denzin NK, Mettlin CJ. Incomplete
professionalization: the case of phar-
macy. Soc Forces 1968; 46: 375–381.
2. Harding G, Taylor K. Responding to
change: the case of community phar-
macy in Great Britain. Sociol Health
Illn 1997; 19: 547–560.
3. Sleath B, Campbell W. American
pharmacy: a profession in the final
stage of dividing? J Pharm Mark
Manage 2001; 14: 1–25.
4. Nuffield Foundation. Pharmacy: the
report of a committee of inquiry
appointed by the Nuffield Foundation.
London: Nuffield Foundation; 1986.
5. Smith J, Picton C, Dayan M. Now or
never: shaping pharmacy for the
future. London: Royal Pharmaceuti-
cal Society, 2013.
6. Spinks J et al. Disruptive innovation
in community pharmacy–impact of
automation on the pharmacist work-
force. Res Soc Adm Pharm 2017; 13:
394–397.
7. NHS Digital. scr-in-community-phar-
macy-viewing-figures-300420. 2020:
https://digital.nhs.uk/services/summa
ry-care-records-scr/summary-care-rec
ord-scr-in-communitypharmacy/
your-community-pharmacys-scr-view
ing-figures (accessed 7 May 2020).
8. Brown TJ et al. Community phar-
macy-delivered interventions for
public health priorities: a systematic
review of interventions for alcohol
reduction, smoking cessation and
weight management, including meta-
analysis for smoking cessation. BMJ
Open 2016; 6: e009828.
9. Root G, Varney J. Pharmacy: A Way
Forward for Public Health Opportuni-
ties for action through pharmacy for
public health. London: Public Health
England. 2017.
10. Nancarrow SA, Borthwick AM.
Dynamic professional boundaries in
the healthcare workforce. Sociol
Health Illn 2005; 27: 897–919.
11. Latif A et al. ‘I expected just to walk
in, get my tablets and then walk
out’: on framing new community
pharmacy services in the English
healthcare system. Sociol Health Illn
2018; 40: 1019–1036.
© 2020 The Authors. International Journal of Pharmacy Practice
published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society
International Journal of Pharmacy Practice 2020, 28, pp. 205--206
206
